Company bioAffinity Technologies, Inc.
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 USD | +1.76% | -3.75% | +57.09% |
May. 15 | BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Laboratory Services
99.2
%
| - | - | 3 | 99.2 % | - |
Diagnostic Research and Development
0.8
%
| - | - | 0 | 0.8 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 3 | 100.0 % | +52,627.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Director of Finance/CFO | 45 | 23-04-30 | |
David Elzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Vivienne Rebel
CTO | Chief Tech/Sci/R&D Officer | 59 | 15-12-31 |
Xavier Reveles
COO | Chief Operating Officer | 55 | 16-12-31 |
Julie Overton
IRC | Investor Relations Contact | - | 23-02-12 |
Dallas Coleman
SAM | Sales & Marketing | - | Nov. 05 |
William Bauta
PRN | Corporate Officer/Principal | - | - |
Jennifer Rebeles
PRN | Corporate Officer/Principal | - | 18-12-31 |
Timothy Zannes
LAW | General Counsel | 72 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Girgenti
CHM | Chairman | 78 | 14-02-28 |
Peter Knight
BRD | Director/Board Member | 73 | 18-04-30 |
Stuart Diamond
BRD | Director/Board Member | 63 | 21-12-31 |
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Robert Anderson
BRD | Director/Board Member | 84 | 14-03-31 |
Gary Rubin
BRD | Director/Board Member | 68 | 17-11-28 |
Jamie Platt
BRD | Director/Board Member | - | Nov. 30 |
Roby Joyce
BRD | Director/Board Member | 76 | 23-09-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,657,537 | 7,622,402 ( 65.39 %) | 0 | 65.39 % |
Company contact information
bioAffinity Technologies, Inc.
22211 West Interstate 10 Suite 1206
78257, San Antonio
+
http://www.bioaffinitytech.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+57.09% | 26.14M | |
-6.76% | 12.28B | |
-5.12% | 8.05B | |
+7.95% | 5.84B | |
+31.44% | 5.66B | |
-12.56% | 3.99B | |
+12.16% | 2.7B | |
-60.83% | 2.7B | |
-7.65% | 2.39B | |
+14.79% | 2.02B |
- Stock Market
- Equities
- BIAF Stock
- Company bioAffinity Technologies, Inc.